People | February 22, 2022
PrecisionLife appoints Colin Stubberfield as SVP Drug Discovery
He will be responsible for developing the company's pipeline of partnered and in-house discovery programs,
He will be responsible for developing the company's pipeline of partnered and in-house discovery programs,
The deepCDR engine combines deep sequencing and deep learning methods with a proprietary mammalian display process to select from a wide range of antibodies and rapidly identify candidates with the highest possible affinity and developability profiles
Purchase price of US $ 1.5 billion upfront and up to USD 500 million in success-based milestone payments
The move strengthens GBL’s clinical-stage presence in the United States
The randomized, double-blind, placebo-controlled single ascending dose (SAD) study evaluated safety, tolerability, pharmacokinetics, and target engagement in 46 healthy participants
More than five drug candidates from his team progressed to human trials including drugs like Rilematovir (Phase IIb), and Bedaquiline
The companies aim to expand treatment options for millions living with metabolic disorders
Terray and BMS aim to accelerate small molecule drug discovery by harnessing EMMI’s integrated experimental and AI capabilities
These initiatives will harness top scientific talent and advanced AI technologies to develop new ways to slow the rise of drug-resistant infections
Exemplifies commitment of Merck to energy efficiency and sustainable practices in high-performance computing by featuring advanced water-cooling systems and a hybrid cloud infrastructure
Subscribe To Our Newsletter & Stay Updated
